期刊文献+

再生丝素膜对转基因角膜上皮细胞表达细胞因子的影响

Impact of regenerated silk protein membrane on the cytokine expression of transfected human corneal epithelium cells
原文传递
导出
摘要 目的探讨再生丝素膜对转基因人角膜上皮细胞表达细胞因子的影响,以及转基因细胞修饰的再生丝索膜构建生物材料复合体的可能性。方法实验研究。兔角膜缘注射重组腺病毒载体血管内皮生长因子165(Ad-VEGF165)诱导新生血管,测量角膜新生血管生长面积,分析角膜组织血管内皮细胞生长因子免疫组织化学结果。用再生丝素膜培养角膜上皮细胞,观察细胞形态、生长曲线、Ad—VEGF165感染效率。收集再生丝素膜Ad—VEGF165转基因角膜上皮细胞培养上清,酶联免疫吸附试验法检测上清中血管内皮生长因子、血管生成素1、表皮生长因子、转化生长因子等细胞因子浓度。采用双因素方差分析基因感染和再生丝素膜材料两因素对HCECs细胞因子表达水平的比较。结果(1)角膜缘注射Ad-VEGF165后第1周、第1个月角膜新生血管面积分别为(7.60±1.12)mm^2、(12.28±2.54)mm^2,注射后第3天、第1周、第1个月角膜基质内可见血管内皮生长因子阳性表达。(2)再生丝素膜及无再生丝素膜两种培养条件,角膜上皮细胞细胞形态、生长曲线、Ad-VEGF165感染效率均无明显差异。(3)再生丝素膜培养Ad-VEGF165转基因角膜上皮细胞上清中各细胞因子浓度分别为血管内皮生长因子(721.67±66.97)ng/L、表皮生长因子(1042.67±315.81)ng/L、血管生成素1(2421.00±0.00)ng/L、转化生长因子(313.33±34.06)ng/L。无再生丝素膜Ad-VEGF165转基因角膜上皮细胞培养上清各细胞因子浓度分别为血管内皮生长因子(721.67±66.97)ng/L、表皮生长因子(860.33±315.81)ng/L、血管生成素1(1960.33±797.90)ng/L、转化生长因子(278.00±53.11)ng/L。Ad—VEGF165感染角膜上皮细胞培养上清中各细胞因子浓度均显著高于对照组,分别为血管内皮生长因子(F=168.16,P〈0.0001)、表皮生长因子(F=52.76,P〈0.0001)、血管生成素1(F=12.47,P=0.001)、转化生长因子(F=5.647,P=0.016)。再生丝素膜与无再生丝素膜两种培养条件下,血管内皮生长因子(F=0.071,P=0.793)、表皮生长因子(F=0.563,P=0.465)、血管生成素1(F=0.14,P=0.714)、转化生长因子(F=0.008,P=0.932)浓度比较差异无统计学意义。结论再生丝素膜与细胞培养板一样,Ad-VEGF165转基因角膜上皮细胞目的基因能获得高效表达,同时还使角膜上皮细胞自分泌的新生血管相关细胞因子表皮生长因子、血管生成素1、转化生长因子等获得高效表达。 Objective The purpose of this research was to study the influence of the regenerated silk fibroin film (SF) on cytokines expression of transfected human corneal epithelial cells (HCECs) and to investigate the possibility of constructing biomaterial complex using SF, modified by transgenic cells.Methods Empirical study. Ad-VEGF165 was injected into the limbus of a rabbit's cornea to induce cornea neovascularization (CNV). CNV was evaluated by growth areas and VEGF characteristic was evaluated by immunohistochemistry. HCECs was cultivated on silk protein membrane in the cell cultivation plate. Modality of cells, activity of cell proliferation and infection efficiency of Ad-VEGF165 were monitored to evaluate the biocompatibility of silk fibroin. The angiogenesis-related cytokines in the cell cuhivation supernatant was measured using ELISA method such as vascular endothelial growth factor (VEGF), angiogenin 1 (Angl), epidermal growth factor (EGF) and transforming growth factor-beta (TGF-β) in the supernatant ( Two-way analysis of variance). Results ( 1 ) The area of corneal neovascularization was observed to be ( 7.60 ± 1.12 ) mm^2 at 1 week after Ad-VEGF165 was injected and it became ( 12.28± 2. 54)mm^2 another three weeks later. Positive expression of VEGF in corneal stromal was observed by immunohistochemistry at 3 d, 1 week and 1 month after injection. (2) There was no difference noticed in morphous, growth curve and infection efficiency of Ad-VEGF165 between both cells culture conditions of silk protein membrane and plate cultivation. (3) After transfection, the concentration of VEGF, Angl, EGF and TGF-β expressions in the corneal epithelium cell cultivation supernatant with silk protein membrane as carriers was (721.67 ±66.97) ng/L,(1042. 67 ±315.81) ng/L, (2421.00 ±0.00) ng/L, and (313.33 ± 34. 06) ng/L respectively; and the concentration of each of the aforementioned expression was (721.67 ± 66. 97) ng/L, ( 860. 33 ± 315.81 ) ng/L, ( 1960. 33± 797.90) ng/L, and (278.00 ± 53.11 ) ng/L without using silk protein membrane as carriers. The increase of VEGF (F = 168. 16, P 〈 0. 0001 ), EGF (F=52.76,P〈0.0001), Angl(F=12.47,P=0.001), and TGF-β(F=0.008,P=0.932)in the Ad-VEGF165 group was considered statistically significant; however, there was no evident change in the concentration of VEGF ( F = 0. 071, P = 0. 793 ), EGF ( F = 0. 563, P = 0. 465 ), Angl ( F = 0. 14, P = 0. 714), and TGF-β (F = 0. 008, P = 0. 932)expressions in the corneal epithelium cell cultivation supernatant both with or without using silk protein membrane as carriers. Conclusion Same as cell HCECs culturing in the cultivation plate, through SF application, VEGF165 destination gene could be high-level expressed in the supernatant having which the HCECs is cultured on SF, and in addition, the angiogenesisrelated cytokines content of Angl, EGF, and TGF-β autocrined in the HCECS cultivation supernatant could be high-level expressed as well.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2009年第11期992-998,共7页 Chinese Journal of Ophthalmology
基金 基金项目:国家重点基础研究发展计划(973计划)项目(2005CB623900) 苏州大学医学发展基金项目(EE134702)
关键词 丝素蛋白 上皮 角膜 上皮细胞 腺病毒科 血管内皮生长因子A Silk Epithelium,corneal Epithelial cells Adenoviridae Vascular endothelial growth factor A
  • 相关文献

参考文献20

  • 1Trail IA, Martin JA, Nuttall D, et al. Seventeen-year survivorship analysis of silastic metacarpophalangeal joint replacement. Bone Joint Surg Br, 2004, 86: 1002-1006.
  • 2Asai T, Lee MH, Arrecubieta C, et al. Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus. Thorac Cardiovasc Surg, 2007, 133:1147-1153.
  • 3Lin YM, Boccaccini AR, Polak JM, et al. Biocompatibility of poly-DL-lactic acid (PDLLA) for lung tissue engineering. Biomater Appl, 2006,21 : 109 -118.
  • 4Yoshitani M, Fukuda S, hoi S, et al. Experimental repair of phrenic nerve using a polyglycolic acid and collagen tube. Thorac Cardiovasc Surg, 2007,133:726-732.
  • 5Altman GH, Diaz F, Jakuba C, et al. Silk-based biomaterials. Biomaterials, 2003,24:401-416.
  • 6刘铁连,谢宇锋,盛伟华,缪竞成,单云波,胡志清,井莹莹,杨吉成.人血管生成素1和血管内皮生长因子165重组腺病毒载体构建及目的基因表达[J].中国组织工程研究与临床康复,2008,12(41):8103-8106. 被引量:6
  • 7D'Amato RJ, Loughnan MS, Flynn E,et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA, 1994, 91: 4082-4085.
  • 8Fang JY, Chen JP, Liu YL,et al. Characterization and evaluation of silk protein hydrogels for drug delivery. Chem Pharm Bull, 2006,54 : 156-162.
  • 9Li M, Ogiso M, Minoura N. Enzymatic degradation behavior oporous silk fibroin sheets. Biomaterials, 2003,24:357-365.
  • 10Chiarini A, Petrini P, Bozzini S, et al. Silk fibroin/poly (carbonate)-urethane as a substrate for cell growth: in vitro interactions with human ceils. Biomaterials,2003 ,24 :789-799.

二级参考文献13

  • 1潘秀花,杨占山,杨淑琴,岳凌,潘鹏.在创伤愈合中VEGF和Ang-1表达的生物动力学变化研究[J].苏州大学学报(医学版),2006,26(2):178-181. 被引量:9
  • 2单志新,符永恒,余细勇,林秋雄,邓春玉,郑猛.VEGF_(165)和Angiopoietin-1 cDNA治疗缺血心肌的实验研究[J].心肺血管病杂志,2006,25(2):114-117. 被引量:4
  • 3黄泉,杨吉成,缪竞诚,刘春宇,谢宇锋,盛伟华,李明忠.再生丝素膜生物相容性的实验研究[J].苏州大学学报(工科版),2007,27(2):1-4. 被引量:4
  • 4Roy L, Holle W, Song E, et al. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res 2002; 22(6): 3185-3189.
  • 5Bramson JL, Hitt M, Gauldie J, et al. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 1997;4(10): 1069-1076.
  • 6He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95(5):2509-2514.
  • 7Ryu JK, Cho CH, Shin HY, et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006;13(4):705-715.
  • 8Lim HSI Blann AD, Chong AY, et al. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes : implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 2004; 27(12): 2918-2924.
  • 9Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-l, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87(7): 1171 - 1180.
  • 10Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin- 1. Science 1999;286(5449) :2511-2514.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部